Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Tuberculosis and Respiratory Diseases is Scopus-indexed (Q2, CiteScore 4.6), WoS ESCI, DOAJ. Published by The Korean Academy of Tuberculosis and Respiratory Diseases.
Checked against the index lists dated .
ISSN 1738-3536Verify ISSN ↗2005-6184Verify ISSN ↗
Publisher: The Korean Academy of Tuberculosis and Respiratory Diseases
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 57 / 165 | 65th | Q2 |
| Infectious Diseases | 135 / 361 | 62nd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1980–present, best quartile Q2, CiteScore 4.6.
Tuberculosis and Respiratory Diseases is Q2 in Pulmonary and Respiratory Medicine (rank 57 of 165) and Q2 in Infectious Diseases (rank 135 of 361), by CiteScore 2025.
Tuberculosis and Respiratory Diseases is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.6, which places it in quartile Q2 at the 65th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.798, quartile Q2, with an H-index of 41.
Tuberculosis and Respiratory Diseases is published by The Korean Academy of Tuberculosis and Respiratory Diseases. Its print ISSN is 1738-3536 and its online ISSN is 2005-6184.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Tuberculosis and Respiratory Diseases has an h-index of 47 and a 2-year mean of 3.19 citations per paper (OpenAlex). Its Scopus CiteScore is 4.6, quartile Q2. On 2-year citations it ranks #22 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Tuberculosis and Respiratory Diseases published 80 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from South Korea (76.1%), United States (3.5%) and India (3.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.